DHA 40mg / PPQ 320mg, blister of 9 tab., 35-74 kg

STD DORADHAP4T1

Valid Article

Former Code(s): DORADHAP04-
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF05
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

DIHYDROARTEMISININ (DHA)/PIPERAQUINE (PPQ)

Therapeutic Action

Fixed-dose combination (FDC) of two antimalarials

Indications

First or second-line treatment of uncomplicated malaria, depending on the context

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Blister presentation for 3 days treatment.

5 different presentations for 5 categories of weight:

WeightStrenghtPresentationCode
5-12 kg20 / 160 mg3 disp. tabs / blisterDORADHAP1T1
13-23 kg40 / 320 mg3 disp. tabs / blisterDORADHAP2T1
24-24 kg40 / 320 mg6 disp. tabs / blisterDORADHAP3T1
35-74 kg40 / 320 mg9 disp. tabs / blisterDORADHAP4T1
75-100 kg40 / 320 mg12 disp. tabs / blisterDORADHAP5T1

Presentations must be ordered for all 5 weight categories.

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • Shelf life: maximum 24 months